No description yet.
Pittsburgh, PAFounded 2012
1 source · checked 1 time, last 4h ago
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The SEC source identifies a Form D securities offering and filing date, but states no round stage, amount, valuation, investors, announcement date, or headquarters.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Form D (equity) | n/a | 2026-09-30 | not stated | No recent discussion |
1 source · checked 1 time, last 4h ago [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source
The SEC source identifies a Form D securities offering and filing date, but states no round stage, amount, valuation, investors, announcement date, or headquarters. [ BUILT WITH ]·[ SEARCH ]from a Form D filing·[ SCRAPE ]1 page read: sec.gov·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 1 source·[ AGENT ]company research by the Firecrawl agent | ||||
| EARLIER ROUNDS FROM COMPANY RESEARCH · DEVELOPING | ||||
| Later Stage VC | $587,465 | 2020-06-05 | not stated | |
PECA Labs builds polymeric cardiovascular implants, including vascular grafts and heart valves, for pediatric and adult patients, especially those with congenital heart defects.
Checked against 11 sources today
None named.